Pharmaceutical organizations are increasingly becoming prime targets for cybercriminals. From valuable intellectual property and clinical trial data to sensitive healthcare records, the industry faces growing cybersecurity risks that can impact operations, patient safety, and trust.

Our latest Point of View report, “Pharma in 2025: Cybersecurity Challenges,” explores the evolving threat landscape and highlights the key security challenges pharmaceutical and chemical companies must address to stay protected.

In this report, you will discover:

• The biggest cybersecurity threats facing pharmaceutical companies today
• How IT and operational technology convergence increases security risks
• Real world examples of cyberattacks impacting global pharma organizations
• Strategies to strengthen security across supply chains and critical infrastructure

With cyber threats becoming more sophisticated, having the right security strategy is essential to protect innovation, ensure compliance, and maintain trust across the healthcare ecosystem.